期刊
ANNUAL REVIEW OF IMMUNOLOGY VOL 33
卷 33, 期 -, 页码 417-443出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-immunol-032414-112134
关键词
inflammation; autoimmunity; infectious disease; IL-10; IL-17
类别
资金
- Grants-in-Aid for Scientific Research [25460594] Funding Source: KAKEN
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110201] Funding Source: NIH RePORTER
Interleukin-27 (11-27) is a cytokine with strikingly diverse influences on the immune response. Although it was initially linked with the development of Th1 responses, it is now- recognized as a potent antagonist of different classes of inflammation through its ability to directly modify CD4(+) and CD8(+) Teen effector functions, to induce IL-10. and to promote specialized T regulatory cell responses. Although this aspect of IL-27 biology has provided insights into how the immune system prevents hyperactivity in the setting of infectious and autoimmune inflammation, in vaccination and cancer models the stimulatory effects of IL-27 on CD8(+) cell function appear prominent. Additionally, associations between IL-27 and antibody-mediated disease have led to an interest in defining the impact of IL-27 on innate immunity and humoral responses in different disease states. The maturation of this literature has been accompanied by attempts to translate these findings from experimental models into human diseases and by efforts to define where IL-27 might represent a viable therapeutic target.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据